Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders

被引:182
作者
Takahashi, T
Kondoh, T
Fukuda, M
Yamazaki, Y
Toyosaki, T
Suzuki, R
机构
[1] Akita Univ, Sch Med, Div Oral & Maxillofacial Surg, Akita 010, Japan
[2] Yokohama Rosai Hosp, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan
[3] Shionogi & Co Ltd, Shionogi Res Labs, Dept Immunol & Bioregulat, Osaka, Japan
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS | 1998年 / 85卷 / 02期
关键词
D O I
10.1016/S1079-2104(98)90415-2
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. To measure the levels of the proinflammatory cytokines, interleukin (IL)-1 beta, IL-6, tumor necrosis factor-(TNF)alpha, IL-8, and interferon-(IFN)gamma in synovial fluid samples taken from patients with temporomandibular disorders (TMD). Study design. We studied 6 asymptomatic volunteers and 51 patients with TMD. The IL-1 beta, IL-6, TNF-alpha, IL-8, and IFN-gamma levels in temporomandibular joint synovial fluid were measured using enzyme-linked immunosorbent assay. Results. Measurable level of at least. one cytokine in the synovial fluid was found in 40 (64.5%) of 62 joints in the patients: IL-1 beta and IFN-gamma were each detected in 18 (29.0%) of 62 joints; IL-6 in 13 (21.0%) of 62 joints; IL-8 in 11 (19.3%) of 57 joints; and TNF-alpha in only 5 (8.1%) of 62 joints. None of these cytokines was detectable in the synovial fluid in the control group. Furthermore, there was a strong correlation between the detection of IL-1 beta and pain in the joint area. Conclusions. These data clearly demonstrate increased levels of several proinflammatory cytokines in certain patients with TMD and suggest that these cytokines may play a role in the pathogenesis of synovitis and degenerative changes of the cartilaginous tissue and bone of the temporomandibular joint.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 39 条
  • [1] DETERMINATION OF TEMPOROMANDIBULAR-JOINT FLUID CONCENTRATIONS USING VITAMIN-B-12 AS AN INTERNAL STANDARD
    ALSTERGREN, P
    APPELGREN, A
    APPELGREN, B
    KOPP, S
    LUNDEBERG, T
    THEODORSSON, E
    [J]. EUROPEAN JOURNAL OF ORAL SCIENCES, 1995, 103 (04) : 214 - 218
  • [2] AREND WP, 1994, J IMMUNOL, V153, P4766
  • [3] CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS
    AREND, WP
    DAYER, JM
    [J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (03): : 305 - 315
  • [4] STIMULATION OF HUMAN CHONDROCYTE PROSTAGLANDIN-E2 PRODUCTION BY RECOMBINANT HUMAN INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR
    CAMPBELL, IK
    PICCOLI, DS
    HAMILTON, JA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1051 (03) : 310 - 318
  • [5] DASILVA JAP, 1994, J RHEUMATOL, V21, P330
  • [6] HUMAN RECOMBINANT INTERLEUKIN-1 STIMULATES COLLAGENASE AND PROSTAGLANDIN E-2 PRODUCTION BY HUMAN SYNOVIAL-CELLS
    DAYER, JM
    DEROCHEMONTEIX, B
    BURRUS, B
    DEMCZUK, S
    DINARELLO, CA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) : 645 - 648
  • [7] TUMOR NECROSIS FACTOR IN SYNOVIAL EXUDATES
    DIGIOVINE, FS
    NUKI, G
    DUFF, GW
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (09) : 768 - 772
  • [8] DINARELLO CA, 1991, BLOOD, V77, P1627
  • [9] Fu Kaiyuan, 1995, Journal of Orofacial Pain, V9, P131
  • [10] TUMOR-NECROSIS-FACTOR IN SYNOVIAL-FLUID OF PATIENTS WITH TEMPOROMANDIBULAR DISORDERS
    FU, KY
    MA, XC
    ZHANG, ZK
    CHEN, WF
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1995, 53 (04) : 424 - 426